MEDFORD, Ore. — The Oregon Health Authority is expecting to lift requirements that led to rationing the use of a $1,000-per-pill drug that can cure hepatitis C.
Most patients covered by the Oregon Health Plan had to have liver damage in order to qualify for the hepatitis C cure, the Mail Tribune reported Wednesday.
Thank you for reading The Columbian.
Subscribe for only $99/year to get unlimited access.
Your tax-deductible donation to The Columbian’s Community Funded Journalism program will contribute to better local reporting on key issues, including homelessness, housing, transportation and the environment. Reporters will focus on narrative, investigative and data-driven storytelling.
Local journalism needs your help. It’s an essential part of a healthy community and a healthy democracy.
